NCT06257693View on ClinicalTrials.gov

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
Prostate Adenocarcinoma
Interventions
DRUG

enzalutamide

Localized single delivery of the Enolen implant (polymer + enzalutamide) with planned radical prostatectomy

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alessa Therapeutics Inc.

INDUSTRY